Login / Signup

Estimating the Prevalence of Cardiac Amyloidosis in Old Patients with Heart Failure-Barriers and Opportunities for Improvement: The PREVAMIC Study.

Rocío Ruiz-HuesoPrado Salamanca-BautistaMaria Angustias Quesada-SimónSergi YunAlicia Conde-MartelJosé Luis Morales-RullRoi Suárez-GilJosé Ángel García-GarcíaPau LlàcerEva María Fonseca-AizpuruBeatriz Amores-ArriagaÁngel Martínez-GonzálezArola Armengou-ArxeJosé Luis Peña-SomovillaManuel Lorenzo López-ReboiroÓscar Aramburu-Bodasnull null
Published in: Journal of clinical medicine (2023)
CA was the cause of HF in one out of five patients and should be screened in the elderly with HF and myocardial thickening, regardless of sex and LVEF. Few transthyretin-gene-sequencing studies were performed in older patients. In many patients, it was not possible to determine the amyloid subtype.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • ejection fraction
  • left ventricular
  • prognostic factors
  • single cell
  • patient reported outcomes
  • dna methylation